Shree Maruti Nandan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.29 Cr
as on 16-11-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.87 Cr
as on 16-11-2024
- Satisfied Charges ₹ 24.78 Cr
as on 16-11-2024
- Revenue -11.16%
(FY 2023)
- Profit -11.66%
(FY 2023)
- Ebitda 6.40%
(FY 2023)
- Net Worth 13.32%
(FY 2023)
- Total Assets -2.00%
(FY 2023)
About Shree Maruti Nandan Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.29 Cr.
The company currently has active open charges totaling ₹14.87 Cr. The company has closed loans amounting to ₹24.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Brijesh Kumar, Anurag Agarwal, and Gaurav Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24232DL2013PTC250434
- Company No.
250434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2013
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shree Maruti Nandan Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijesh Kumar  | Director | 19-Feb-2019 | Current |
| Anurag Agarwal | Director | 20-Jun-2013 | Current |
| Gaurav Aggarwal | Director | 19-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Shree Maruti Nandan Pharmaceuticals.
Shree Maruti Nandan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.16% decrease. The company also saw a substantial fall in profitability, with a 11.66% decrease in profit. The company's net worth Soared by an impressive increase of 13.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Maruti Nandan Pharmaceuticals?
In 2021, Shree Maruti Nandan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2023 | ₹14.71 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Jan 2023 | ₹1.61 M | Open |
Axis Bank Limited Creation Date: 07 Aug 2023 | ₹1.41 Cr | Satisfied |
How Many Employees Work at Shree Maruti Nandan Pharmaceuticals?
Shree Maruti Nandan Pharmaceuticals has a workforce of 40 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Maruti Nandan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Maruti Nandan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
